Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCash Due from BankCommon EquityGoodwillGoodwill & IntangiblesIntangiblesInterest DepositsLiabilities and Shareholders EquityLoansLoans - GrossLoans - Loss AllowanceLoans - NetNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Retained EarningsSecurities - Held-to-maturitySecurities - TradableShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

UNIVEST FINANCIAL (UVSP) Payables: 2016-2025

Historic Payables for UNIVEST FINANCIAL (UVSP) over the last 10 years, with Sep 2025 value amounting to $7.2 billion.

  • UNIVEST FINANCIAL's Payables rose 5.36% to $7.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $27.3 billion, marking a year-over-year increase of 4.17%. This contributed to the annual value of $6.8 billion for FY2024, which is 6.09% up from last year.
  • Per UNIVEST FINANCIAL's latest filing, its Payables stood at $7.2 billion for Q3 2025, which was up 9.73% from $6.6 billion recorded in Q2 2025.
  • UNIVEST FINANCIAL's Payables' 5-year high stood at $7.2 billion during Q3 2025, with a 5-year trough of $5.3 billion in Q1 2021.
  • In the last 3 years, UNIVEST FINANCIAL's Payables had a median value of $6.5 billion in 2024 and averaged $6.6 billion.
  • In the last 5 years, UNIVEST FINANCIAL's Payables increased by 20.62% in 2021 and then dropped by 1.42% in 2022.
  • Quarterly analysis of 5 years shows UNIVEST FINANCIAL's Payables stood at $6.1 billion in 2021, then grew by 0.58% to $6.1 billion in 2022, then increased by 4.44% to $6.4 billion in 2023, then rose by 6.09% to $6.8 billion in 2024, then increased by 5.36% to $7.2 billion in 2025.
  • Its Payables was $7.2 billion in Q3 2025, compared to $6.6 billion in Q2 2025 and $6.7 billion in Q1 2025.